Immucor
BLUD today reported financial results for its fiscal 2011 second quarter ended November 30, 2010.
Highlights
Revenue for the second quarter of fiscal 2011 was $81.5 million, down approximately $1.0 million or 1% from the prior year quarter. Current quarter revenue was negatively impacted by approximately $1.0 million from fluctuations in foreign currency exchange rates.
Gross margin was 71.6% in the quarter compared with 70.4% in the prior year quarter.
Diluted earnings per share totaled $0.30 in the quarter compared with $0.28 for the same period last year.
Cash flow from operations for the six months ended November 30, 2010 was $47.7 million compared with $34.1 million in the prior year.
Worldwide instrument orders for the second quarter of fiscal year 2011 were 29 Echo® orders and 26 NEO® orders. NEO is the Company's new high volume instrument that was recently launched worldwide.
Loading...
Loading...
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Posted In:
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in